Biotech Industry, Biotech News, Biotechnology Articles, d pharma.#D #pharma


Posted On Jan 17 2018 by

d pharma

Certain microRNAs in the saliva of concussion patients could help gauge the severity of concussions and predict the length of concussion symptoms.

D pharma

Toxicity knocks Ardelyx s hyperkalemia hopes back to preclinic

Unexpected side effects have spelled the end for Ardelyx’s drug candidate to treat elevated potassium levels in the blood, which was in phase 3 testing.

D pharma

Cytokinetics cans lead drug after phase 3 ALS wipeout

Cytokinetics canned tirasemtiv after it failed to beat placebo against the primary endpoint or any of the secondary goals in an ALS trial.

D pharma

Step Pharma bags cash for CTPS1 autoimmune R D drive

The $17 million financing equips the lean French biotech to prepare its CTPS1 inhibitors for clinical testing in autoimmune disorders.

D pharma

PTK6 blocker could treat or even prevent ER+ breast cancer metastasis

The enzyme PTK6 could be targeted to quell the growth of estrogen receptor-positive breast cancer, a common form of the disease.

D pharma

Amsterdam beats out Milan to host EMA

After tying with Milan in a third round of voting, Amsterdam will be the new home of the European Medicines Agency.

D pharma

LivaNova to offload Cardiac Rhythm unit for $190M

LivaNova will sell its Cardiac Rhythm Management business to its joint venture partner, MicroPort Scientific.

D pharma

DBV climbs as peanut allergy safety data come in clean

Shares in DBV rose on the back of the data, going a little way to erasing the big drop it suffered after missing its primary efficacy endpoint.

D pharma


Last Updated on: January 17th, 2018 at 1:09 pm, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *